We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Novel Clinical Trial Designs for Innovative Therapies.
- Authors
Schellens, J. H. M.; Beijnen, J. H.
- Abstract
There is a paradigm shift in oncology from the development of classical intravenously applied cytotoxic anticancer drugs to so-called targeted therapies with molecules that are often administered orally on a chronic daily basis. The dose-limiting toxicities of targeted therapies are frequently markedly different from those of cytotoxic anticancer drugs. In addition, the activity levels of therapies targeted against defined cellular markers may significantly improve if patient pool enrichment is carried out on the basis of the presence of that specific marker in the tumor tissue. Alternative strategies for clinical development are needed for the swift and safe testing of these novel therapies.
- Subjects
ONCOLOGY; ANTINEOPLASTIC agents; CANCER treatment; CLINICAL medicine; THERAPEUTICS; TUMORS
- Publication
Clinical Pharmacology & Therapeutics, 2009, Vol 85, Issue 2, p212
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1038/clpt.2008.247